GLP-1s Are Only Part of the Story GLP-1 medications often receive the headlines, but theyre only one part of an organizations overall healthcare strategy
Cardiovasc Diabetol 17:62 Correale M, Petroni R, Coiro S, Antohi E-L, Monitillo F, Leone M, Triggiani M, Ishihara S, Dungen H-D, Sarwar CMS, Memo M, Sabbah HN, Metra M, Butler J, Nodari S (in press) Paradigm shift in heart failure treatment: are cardiologists ready to use gliflozins
Kevin Sadati offers patients a quick and simple way to feel better and more energized when diet, sleep, and exercise alone are not enough
QL Biopharms ZT-002 and Amgens MariTide both have long half-life and are targeting once monthly subcutaneous administration as well
Still, clinical trials show it can help lower body weight in people who have excess weight or do not have diabetes